HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.

AbstractOBJECTIVE:
Polycystic ovary syndrome (PCOS) is common and has reproductive and metabolic manifestations. Activin A and follistatin levels remain controversial and activin B levels are unstudied in PCOS. The aim of this study was to evaluate activin A, activin B and follistatin levels and to examine their associations with metabolic status in overweight and obese women with and without PCOS.
MATERIALS AND METHODS:
Cross-sectional study assessing overweight and obese, premenopausal women with PCOS (n=51, n=26 National Institutes of Health (NIH) and n=25 non-NIH) and without PCOS (n=25 controls). Outcomes included activin A, activin B, follistatin and activin A/follistatin ratio and the association of the activins and follistatin with metabolic variables.
RESULTS:
Activin A, activin B and activin A/follistatin ratio were not significantly different and follistatin was elevated for PCOS versus controls (P=0.01) independent of age or BMI. Follistatin levels were significantly different across the PCOS phenotypes (p=0.05), however this was a non-significant trend (after correction for age and BMI) for women with NIH PCOS or non-NIH PCOS to have elevated levels in comparison to controls. Activin A was most strongly predicted by low density lipoprotein/high density lipoprotein (r(2)=0.192, p<0.001), follistatin by triglycerides and highly sensitive C-reactive protein (r(2)=0.340, p<0.001) and the activin A/follistatin ratio by insulin area under the curve and mean arterial pressure (r(2)=0.289, p<0.001).
CONCLUSIONS:
Follistatin is elevated and activins A and B are not different between PCOS and controls. Follistatin and activin A are related to metabolic parameters in women with and without PCOS. Follistatin may potentially act as a marker of or be involved in the pathophysiology of both reproductive and metabolic features of PCOS.
AuthorsHelena Teede, Sze Ng, Mark Hedger, Lisa Moran
JournalMetabolism: clinical and experimental (Metabolism) Vol. 62 Issue 10 Pg. 1394-400 (Oct 2013) ISSN: 1532-8600 [Electronic] United States
PMID23768911 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Biomarkers
  • Follistatin
  • Hormones
  • Insulin
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Triglycerides
  • activin A
  • activin B
  • Activins
  • C-Reactive Protein
Topics
  • Activins (metabolism)
  • Adult
  • Arterial Pressure (physiology)
  • Biomarkers (metabolism)
  • C-Reactive Protein (metabolism)
  • Cross-Sectional Studies
  • Female
  • Follistatin (metabolism)
  • Hormones (metabolism)
  • Humans
  • Insulin (metabolism)
  • Lipoproteins, HDL (metabolism)
  • Lipoproteins, LDL (metabolism)
  • Obesity (metabolism)
  • Overweight (metabolism)
  • Polycystic Ovary Syndrome (metabolism)
  • Premenopause (metabolism)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: